• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Molecular Oncology
    • NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Molecular Oncology
    • NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

    View/Open
    Published version (576.6Kb)
    Volume
    106
    Pagination
    1446 - 1452
    DOI
    10.1038/bjc.2012.95
    Journal
    BRITISH JOURNAL OF CANCER
    Issue
    8
    ISSN
    0007-0920
    Metadata
    Show full item record
    Authors
    Wang, H; Lee, S; Lo Nigro, C; Lattanzio, L; Merlano, M; Monteverde, M; Matin, R; Purdie, K; Mladkova, N; Bergamaschi, D
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7999
    Collections
    • Centre for Molecular Oncology [256]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.